Clinical trial

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

NCT01562327

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Tocilizumab Normalized identity: tocilizumabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2012-02-01

PhaseN/A

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

TocilizumabDRUG · verified · RxNorm: tocilizumab

Sponsors & collaborators

Hoffmann-La Rochelead sponsor

Mapped research locations

Buenos AiresArgentina2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01562327 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.